Leen Delang
Impact in
- Infectious Diseases top 1%
- Viral Infections and Vectors
- Viral Infections and Outbreaks Research
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Virology top 2%
- HIV Research and Treatment
Papers in
- Virology 19
- HIV Research and Treatment 19
-
- Viral Infections and Vectors 22
- HIV/AIDS drug development and treatment 10
- Co-authors
- Johan NeytsRana AbdelnabiPieter LeyssenMatheus FroeyenJan PaeshuyseInge VliegenDirk JochmansMarc Litaudon
- Journals
- Antiviral Research (20 papers)Antimicrobial Agents and Chemotherapy (5 papers)Journal of Natural Products (5 papers)Biochemical Pharmacology (4 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Leen Delang
92 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Infectious Diseases 1.4k
- Virology 259
- Public Health, Environmental and Occupational Health 1.0k
- Hepatology 273
- Insect Science 217
Countries citing papers authored by Leen Delang
This map shows the geographic impact of Leen Delang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leen Delang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leen Delang more than expected).
Fields of papers citing papers by Leen Delang
This network shows the impact of papers produced by Leen Delang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leen Delang. The network helps show where Leen Delang may publish in the future.
Co-authors
The 25 scholars most cited alongside Leen Delang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 6 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 11 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 19 | |
| 9 | 2020 | 19 | |
| 10 | 2019 | 34 | |
| 11 | 2019 | 25 | |
| 12 | 2019 | 9 | |
| 13 | 2019 | 36 | |
| 14 | 2019 | 9 | |
| 15 | Favipiravir as a potential countermeasure against neglected and emerging RNA viruses Hit paper breakdown → | 2018 | 269 |
| 16 | 2018 | 10 | |
| 17 | 2018 | 15 | |
| 18 | 2017 | 53 | |
| 19 | 2017 | 44 | |
| 20 | 2016 | 21 |
About Leen Delang
Leen Delang is a scholar working on Virology, Infectious Diseases, Public Health, Environmental and Occupational Health, Hepatology and Insect Science, having authored 97 papers that have together received 2.7k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (54 papers), Viral Infections and Vectors (22 papers), HIV Research and Treatment (19 papers), Viral Infections and Immunology Research (17 papers), Insect symbiosis and bacterial influences (14 papers), Hepatitis C virus research (14 papers), HIV/AIDS drug development and treatment (10 papers) and interferon and immune responses (9 papers). The work is most often cited by research in Infectious Diseases (1.4k citations), Virology (259 citations), Public Health, Environmental and Occupational Health (1.0k citations), Hepatology (273 citations) and Insect Science (217 citations). Leen Delang has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Johan Neyts, Rana Abdelnabi, Pieter Leyssen, Matheus Froeyen, Jan Paeshuyse, Inge Vliegen, Dirk Jochmans, Marc Litaudon, Gilles Quérat and María‐Jesús Pérez‐Pérez. Their work appears in journals such as Antiviral Research, Antimicrobial Agents and Chemotherapy, Journal of Natural Products, Biochemical Pharmacology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.